Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability.

Julia LederhoferJ van LentF BhoelanZ KarnevaA de HaanJ C WilschutT Stegmann

Published in: Pharmaceutical research (2018)

Stable 3D-PHAD® adjuvanted RSV virosomes can be formulated.

Keyphrases